Stephan Kr henb hl

1.3k total citations
11 papers, 927 citations indexed

About

Stephan Kr henb hl is a scholar working on Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology and Surgery. According to data from OpenAlex, Stephan Kr henb hl has authored 11 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 4 papers in Geriatrics and Gerontology and 3 papers in Surgery. Recurrent topics in Stephan Kr henb hl's work include Pharmaceutical Practices and Patient Outcomes (4 papers), Pharmaceutical studies and practices (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Stephan Kr henb hl is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (4 papers), Pharmaceutical studies and practices (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Stephan Kr henb hl collaborates with scholars based in Switzerland, Chile and Spain. Stephan Kr henb hl's co-authors include Raymond G. Schlienger, Jürgen Drewe, Manuel Haschke, Markus L. Lampert, Lydia Tchambaz, Sabin S Egger, Lorenzo Hess, Irene Blanco, Augusto Gallino and Emile Giostra and has published in prestigious journals such as Transplantation, Drug Safety and Drugs & Aging.

In The Last Decade

Stephan Kr henb hl

11 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephan Kr henb hl Switzerland	11	504	217	180	169	155	11	927
Sander D. Borgsteede Netherlands	21	365 0.7×	114 0.5×	238 1.3×	134 0.8×	31 0.2×	57	968
A.W. Lenderink Netherlands	14	458 0.9×	318 1.5×	178 1.0×	71 0.4×	176 1.1×	20	1.2k
H. J. M. Beijer Netherlands	10	396 0.8×	80 0.4×	199 1.1×	53 0.3×	225 1.5×	23	867
Kirsten K. Viktil Norway	20	1.2k 2.4×	368 1.7×	405 2.3×	105 0.6×	211 1.4×	37	1.7k
Patrick D. Meek United States	13	646 1.3×	240 1.1×	240 1.3×	88 0.5×	29 0.2×	30	1.2k
Steven C. Hartwig United States	4	375 0.7×	205 0.9×	310 1.7×	49 0.3×	460 3.0×	4	930
Fred E. Karch United States	10	197 0.4×	63 0.3×	236 1.3×	107 0.6×	352 2.3×	34	900
Jim Lloyd United States	5	332 0.7×	330 1.5×	150 0.8×	62 0.4×	196 1.3×	7	1.1k
Maria I. Rudis United States	18	355 0.7×	350 1.6×	255 1.4×	170 1.0×	18 0.1×	46	1.6k
Marion Schaefer Germany	16	407 0.8×	129 0.6×	198 1.1×	63 0.4×	107 0.7×	53	1.0k

Countries citing papers authored by Stephan Kr henb hl

Since Specialization

Citations

This map shows the geographic impact of Stephan Kr henb hl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Kr henb hl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Kr henb hl more than expected).

Fields of papers citing papers by Stephan Kr henb hl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Kr henb hl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Kr henb hl. The network helps show where Stephan Kr henb hl may publish in the future.

Co-authorship network of co-authors of Stephan Kr henb hl

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Kr henb hl. A scholar is included among the top collaborators of Stephan Kr henb hl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Kr henb hl. Stephan Kr henb hl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Drewe, Jürgen, et al.. (2007). Risk Factors Associated with a High Velocity of the Development of Hyperkalaemia in Hospitalised Patients. Drug Safety. 30(1). 71–80. 15 indexed citations

Egger, Sabin S, et al.. (2007). Age-Related Differences in the Prevalence of Potential Drug-Drug Interactions in Ambulatory Dyslipidaemic Patients Treated with Statins. Drugs & Aging. 24(5). 429–440. 56 indexed citations

Schlienger, Raymond G., et al.. (2007). Drug-Related Problems in Hospitals. Drug Safety. 30(5). 379–407. 402 indexed citations

hl, Stephan Kr henb, et al.. (2006). The Prevalence of Potential Drug-Drug Interactions in Patients with Heart Failure at Hospital Discharge. Drug Safety. 29(1). 79–90. 61 indexed citations

Tchambaz, Lydia, et al.. (2006). Dose Adaptation of Antineoplastic Drugs in Patients with Liver Disease. Drug Safety. 29(6). 509–522. 16 indexed citations

Egger, Sabin S, et al.. (2006). Prevalence of Potentially Inappropriate Medication Use in Elderly Patients. Drugs & Aging. 23(10). 823–837. 85 indexed citations

Blanco, Irene, Stephan Kr henb hl, & Raymond G. Schlienger. (2005). Corticosteroid-Associated Tendinopathies. Drug Safety. 28(7). 633–643. 44 indexed citations

Tchambaz, Lydia, et al.. (2005). Prevalence of Potentially Severe Drug-Drug Interactions in Ambulatory Patients with Dyslipidaemia Receiving HMG-CoA Reductase Inhibitor Therapy. Drug Safety. 28(3). 263–275. 64 indexed citations

Tchambaz, Lydia, et al.. (2005). Dose Adjustment in Patients with Liver Disease. Drug Safety. 28(6). 529–545. 155 indexed citations

10.

hl, Stephan Kr henb, et al.. (1998). SERIOUS INTERACTION BETWEEN MIBEFRADIL AND TACROLIMUS1. Transplantation. 66(8). 1113–1115. 19 indexed citations

11.

Fattinger, Karin, et al.. (1996). SAFETY OF LIVER DONATION AFTER FATAL INTOXICATION WITH THE TRICYCLIC ANTIDEPRESSANT TRIMIPRAMINE. Transplantation. 62(9). 1259–1262. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact